Xenetic Biosciences, Inc. (XBIO) Income Annual - Discounting Cash Flows
XBIO
Xenetic Biosciences, Inc.
XBIO (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
Report Filing 2025-05-13 2025-05-13 2024-04-26 2023-04-28 2022-03-22 2021-04-28 2020-03-26 2019-04-30 2018-04-30 2017-03-31 2016-03-30 2015-04-30 2014-04-15 2012-12-31
Revenue 2.58 2.5 2.54 1.71 1.16 0.437 0.017 0 7.58 3 0 0 1 0.294
Cost of Revenue 0 0 0 0.027 0.035 0 0 0.016 0.156 0.036 0.056 0 0.008 0.045
Gross Profit 2.58 2.5 2.54 1.68 1.13 0.437 0.017 -0.016 7.43 2.96 -0.056 0 0.992 0.249
Operating Expenses 6.46 6.7 7.06 8.4 6.87 -4.11 12.9 7.26 11 50.39 9.77 12.92 9.61 6.59
Research & Development 3.22 3.29 3.49 4.77 3.16 1.73 4.89 2.88 4.06 43.74 3.43 6.32 3.06 1.94
Selling, General and Administrative 3.24 3.42 3.56 3.65 3.74 3.4 4.73 4.39 6.94 6.69 6.39 6.6 6.55 3.56
Other Operating Expenses 0 0 0 -0.027 -0.035 -9.24 3.28 -0.016 0 -0.036 -0.056 0 -0.008 1.09
Operating Income -3.88 -4.2 -4.52 -6.72 -5.75 4.55 -12.89 -7.28 -3.57 -47.43 -9.82 -12.92 -8.61 -6.34
Net Non-Operating Interest 0.216 0.25 0.356 0.167 0.1 0.126 0.217 -0.024 0.015 -0.73 -0.265 0.014 0.034 0.016
Interest Income 0.216 0.25 0.356 0.167 0.1 0.126 0.217 0 0.017 0 0.002 0.019 0.035 0.068
Interest Expense 0 0 0 0 0 0 0 0.024 0.002 0.73 0.267 0.005 0.001 0.052
Equity & Other Income/(Expense) -0.006 -0.006 0.025 -0.002 0.001 -18.49 -0.105 0 -0.041 -6.05 -2.42 -1.4 0 0
Income Before Tax -3.67 -3.96 -4.13 -6.55 -5.65 -13.81 -12.78 -7.3 -3.6 -54.21 -12.51 -14.31 -8.58 -6.33
Income Tax Expense 0 0 0 -0.166 -0.1 -2.92 3.17 0.024 0.026 6.05 2.42 1.4 -0.034 1.09
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 -0.024 -0.026 -6.05 -2.42 -1.4 0.034 -1.09
Net Income -3.67 -3.96 -4.13 -6.39 -5.54 -10.89 -15.95 -7.3 -3.6 -54.21 -12.51 -14.31 -8.58 -6.33
Depreciation and Amortization 0 0 -0.028 0.027 0.035 0.029 0.027 0.016 0.024 0.036 0.056 0.089 0.052 0.105
EBITDA -3.88 -4.2 -4.54 -6.69 -5.71 4.58 -12.86 -7.26 -3.54 -47.39 -9.77 -12.84 -8.56 -6.24
Earnings Per Share (EPS) -2.38 -2.57 -2.71 -4.49 -5.39 -17.04 -55.92 -96.58 -49.78 -875.4 -355.3 -416.9 -2,835 -2,092
Diluted Earnings Per Share -2.38 -2.57 -2.71 -4.49 -5.39 -17.04 -55.92 -96.57 -49.78 -875.4 -355.3 -416.9 -2,835 -2,092
Weighted Average Shares Outstanding 1.54 1.54 1.53 1.42 1.03 0.639 0.285 0.076 0.072 0.062 0.035 0.034 0.003 0.003
Diluted Weighted Average Shares Outstanding 1.54 1.54 1.53 1.42 1.03 0.639 0.285 0.076 0.072 0.062 0.035 0.034 0.003 0.003
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us